Leuko Labs develops non-invasive white blood cell monitoring device.
Leuko has raised $4.5M in total funding. The most recent round was Grant. The last funding was announced in July 2024.
Leuko's investors include Good Growth Capital, Pegasus Tech Ventures, Nina Capital, IAG Capital Partners, MassVentures.
Leuko is headquartered in Boston, United States.
Leuko Labs develops non-invasive white blood cell monitoring device.
Leuko is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Leuko — Funding & Investors." VCBacked, July 23, 2024, https://www.vcbacked.co/company/leuko. Accessed November 14, 2026.
VCBacked. (2024). Leuko — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/leuko
{{cite web |title=Leuko — Funding & Investors |url=https://www.vcbacked.co/company/leuko |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Leuko? Request a listing update